Clinical Trial Update: A Study of Enfortumab Vedotin in People With Adenoid Cystic Carcinoma [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study of enfortumab vedotin in patients with adenoid cystic carcinoma that is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenoid Cystic Carcinoma

Drugs mentioned

• Padcev (enfortumab vedotin)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Adenoid Cystic Carcinoma | Phase 2 | Status: RECRUITING